In line with these findings, analysis of the TCGC BRCA database linked high expression of USP12 and USP46 with reduced overall survival and progression-free intervals of breast cancer patients (Figs. 8H,I and  EV5B–E). This evidence concerns the gene USP46 and breast cancer.